Rational Design of Vaccines and Immunotherapeutics
joint with Bioterrorism and Emerging Infectious Diseases: Antimicrobials, Therapeutics and Immune-Modulators
Organizer(s): Margaret A. Liu and Peter C. DohertyDate: January 06 - 11, 2004
Location: Keystone Resort, Keystone, CO, USA
The past 2 decades have seen incredible advances in the fields of immunology and molecular biology. Simultaneously, remarkable novel technologies have provided new discovery tools for understanding pathogens and pathophysiology as well as for designing new delivery systems for vaccines and pharmacologic agents. Taken all together, these insights and developments have radically transformed the options for infectious and autoimmune diseases, cancer, and allergy by enabling new targets, new delivery systems, and new types of biologicals. These new agents have the potential to be both more specifically targeted and more precise mechanistically for increased potency and to avoid adverse effects. But to date, and for a variety of reasons, there has been less synergy of all these advances than needed to yield optimal progress towards real breakthrough vaccines and immunotherapies. There is a need for a non-commercial forum that will bring together scientists from the variety of disciplines, from industry as well as academia, and from the different stages of research and development. This meeting will enable scientists from different disciplines and technological backgrounds focusing on various immunological and developmental aspects of vaccines and immunotherapeutics to advance their knowledge in these inter-related areas outside of their own specialties and will provide the opportunity for cross-fertilization and interdisciplinary collaborations. A Keystone Symposium provides an ideal environment for a comprehensive and interactive meeting. The talks are designed to cover critical recent insights that are broadly applicable, while the workshops will enable in-depth coverage of specific topics. Because new technologies and discoveries can be presented in a workshop format, this will enable maximum opportunities for catalysis in order to most rapidly benefit from these diverse insights and developments to develop new ways to harness or control the immune response to prevent or treat the variety of diseases for which the immune system plays a pathological or beneficial role.
Discounted Abstract Deadline: September 15 2003
Discounted Registration Deadline: November 6 2003
We gratefully acknowledge additional support for this conference from: